- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02848703
Study " COFLORES "
Study " COFLORES ":Imaging of Coronary Reserve Without Tracers
Myocardial perfusion is a major parameter characterizing the status of capillary circulation of the myocardium. Its quantification is possible using Magnetic Resonance Imaging (MRI) during the 1st pass of a contrast agent through the capillary system. This technique is radiation-free, but it is difficult to repeat measurements during a single exam. Also, a number of patients suffering from cardiac disease cannot receive contrast agent injections. The investigators have developed a totally non-invasive approach for quantifying myocardial perfusion. It is based on the magnetic labeling of arterial spins. Flowing into the capillaries (Arterial spin labeling, ASL).
Goal : The major goal of this research protocol is to validate a totally non-invasive method of myocardial blood flow quantification using MRI without contrast agent injection
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People having no heart disease or treatment referred to cardiology
- People having no cons -indications to MRI
- People having no cons -indications to gadolinium ;
- People not wearing implantable devices
- People not wearing metallic foreign bodies or risk (eg . Business of steel, etc .. )
- People having no cardiovascular risk factor
- Person subject to the social security scheme
- Nobody agreeing to participate in the study and who signed the informed consent
Exclusion Criteria:
- Refusal to go spontaneous or MRI because of claustrophobia important
- Trouble rhythm making MRI uninterpretable
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: healthy volunteers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myocardial perfusion
Time Frame: 1day
|
MRI based on the magnetic labeling of arterial spins
|
1day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the myocardial energetic status
Time Frame: 1day
|
using phosphorus-31 Magnetic Resonance Spectroscopy
|
1day
|
|
the myocardial sodium
Time Frame: 1day
|
using sodium-23 MRI
|
1day
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2015-45
- 2016-A00026-45 (REGISTRY: ansm)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Perfusion
-
Central Hospital, Nancy, FranceCompleted
-
Hospices Civils de LyonCompletedMyocardial Perfusion ImagingFrance
-
BayerCompletedMagnetic Resonance Imaging | Myocardial Perfusion ImagingSwitzerland, Germany, Austria, Poland
-
Medical University of South CarolinaGuerbetRecruitingMagnetic Resonance Imaging | Myocardial Perfusion ImagingUnited States
-
University of NottinghamFresenius Medical Care Deutschland GmbHCompletedMyocardial Perfusion | Other Postprocedural Cardiac Functional Disturbances
-
Sinotau Pharmaceutical GroupTerminatedStable Coronary Artery Disease | Myocardial Perfusion Imaging | Diagnostic CertaintyChina
-
University of Sao Paulo General HospitalCompleted
-
Mayo ClinicLantheus Medical ImagingCompletedMyocardial Perfusion ImagingUnited States
-
University Hospital Birmingham NHS Foundation TrustCompletedLiver Failure | Myocardial Perfusion Imaging
-
American British Cowdray Medical CenterCompletedCoronary Disease | Magnetic Resonance Imaging | Predictive Value of Tests | Hemodynamics | Positron Emission Tomography | Echocardiography | Coronary Angiography | Multidetector Computed Tomography | Echocardiography, Stress | Fractional Flow Reserve, Myocardial | Myocardial Perfusion Imaging | Humans | Perfusion | Single Photon Emission Computed TomographyMexico
Clinical Trials on Magnetic Resonance Imaging (MRI)
-
University of CincinnatiActive, not recruitingProstate CancerUnited States
-
University of MichiganPhilips Healthcare; General ElectricCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
American College of RadiologyPennsylvania Department of HealthCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGlioma | Brain MassUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedThoracic Spine NeoplasmUnited States
-
University of California, San FranciscoTerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedBreast Cancer | Breast Carcinoma | Neuropathy | Neuropathy;PeripheralUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States, Canada, Korea, Republic of, Saudi Arabia, Mexico, Chile, Colombia
-
Ohio State University Comprehensive Cancer CenterWithdrawn